August 6, 2012

Sandoz has launched a generic version of a topical medication used to treat psoriasis, the company said.

June 14, 2012

Cellceutix on Wednesday reported that the Food and Drug Administration granted a section 505(b) designation for its Prurisol treatment for psoriasis, which would allow the company to forgo early-stage trials and advance Prurisol into latter-stage clinical trials.